Li showed that the expression of HMGB1 was strongly correlated with the clinicopathological features of ESCC patients, and high expression of HMGB1 could shorten the survival of ESCC patients (15). This evidence concerns the gene HMGB1 and esophageal squamous cell carcinoma.